扩散加权磁共振成像预测头颈部鳞状细胞癌放化疗反应:一项系统综述
该系统综述纳入12项研究,评估治疗前表观扩散系数(ADC)及治疗中/后ADC变化对头颈部鳞状细胞癌放化疗或放疗后局部区域失败的预测价值。治疗前高ADC与局部区域失败趋势结果不一致,而所有评估ADC变化的研究均显示局部区域失败患者ADC升高幅度较低。因研究少、异质性大且偏倚风险高,这些参数的敏感度和特异度尚待确定。
要点
- 治疗前高ADC与局部区域失败相关的结果不一致,预测价值有限。
- 治疗中或治疗后ADC升高幅度较低者更可能出现局部区域失败。
- 治疗前ADC预测局部区域失败的敏感度50-100%、特异度79-96%。
核心结论
- 治疗前高ADC以及放化疗期间早期治疗中或治疗后ADC升高幅度较低,可能是头颈部鳞状细胞癌患者局部区域失败的指标;但因研究少、异质性大且偏倚风险高,这些参数预测治疗反应的敏感度和特异度尚待确定。
研究设计与样本
- 系统综述,检索Ovid-MEDLINE和Embase数据库至2018年9月8日,纳入12项关于扩散加权磁共振成像预测头颈部鳞状细胞癌放化疗或放疗后局部区域治疗反应的研究,采用QUADAS-2评估偏倚风险,其中7项研究进行诊断准确性评估。
诊断标准与关键数值
- 治疗前ADC预测局部区域失败的敏感度范围为50-100%,特异度范围为79-96%;ADC变化预测局部区域失败的敏感度范围为75-100%,特异度范围为69-95%。因这些数值明显异质性,未进行Meta分析合并。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 研究数量少。
- 研究间异质性大,未进行Meta分析合并。
- 研究存在高偏倚风险。
- 这些参数预测治疗反应的敏感度和特异度尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically review the evaluation of the diagnostic accuracy of pre-treatment apparent diffusion coefficient (ADC) and change in ADC during the intra- or post-treatment period, for the prediction of locoregional failure in patients with head and neck squamous cell carcinoma (HNSCC).
MATERIALS AND METHODS: Ovid-MEDLINE and Embase databases were searched up to September 8, 2018, for studies on the use of diffusion-weighted magnetic resonance imaging for the prediction of locoregional treatment response in patients with HNSCC treated with chemoradiation or radiation therapy. Risk of bias was assessed by using the Quality Assessment Tool for Diagnostic Accuracy Studies-2.
RESULTS: Twelve studies were included in the systematic review, and diagnostic accuracy assessment was performed using seven studies. High pre-treatment ADC showed inconsistent results with the tendency for locoregional failure, whereas all studies evaluating changes in ADC showed consistent results of a lower rise in ADC in patients with locoregional failure compared to those with locoregional control. The sensitivities and specificities of pre-treatment ADC and change in ADC for predicting locoregional failure were relatively high (range: 50-100% and 79-96%, 75-100% and 69-95%, respectively). Meta-analytic pooling was not performed due to the apparent heterogeneity in these values.
CONCLUSION: High pre-treatment ADC and low rise in early intra-treatment or post-treatment ADC with chemoradiation, could be indicators of locoregional failure in patients with HNSCC. However, as the studies are few, heterogeneous, and at high risk for bias, the sensitivity and specificity of these parameters for predicting the treatment response are yet to be determined.
引用
- Chung SR, Choi YJ, Suh CH, et al. Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review. Korean J Radiol. 2019. PMID: 30887747. doi:10.3348/kjr.2018.0446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。